Summary
A range of bradykinin (BK) analogues was assessed for their ability to antagonise the action of BK on rabbit jugular vein, a B2-receptor containing tissue, and compared with their action against BK-induced increases in skin vascular permeability in the rabbit and rat. The results demonstrate that modification of the BK (nonapeptide) structure by the insertion of certain d-amino acids in positions 5, 7 and 8 in addition to elongation of the amino terminal resulted in compounds with potent antagonistic action against BK on rabbit jugular vein and rabbit skin vascular permeability. The same BK analogues did not antagonise the action of BK on rat skin vascular permeability. It is concluded that the kinin receptor mediating an increase in vascular permeability in the rabbit is the same as that mediating contraction of the rabbit jugular vein in vitro, that is the B2-type. The kinin receptor mediating an increase in skin vascular permeability in the rat is difficult to classify but does not appear to be of the B2 type.
Similar content being viewed by others
References
Bennett AJ, West GB (1980) Local kallikrein and trypsin responses in the rat. Br J Pharmacol 69:625–629
Carr J, Wilhelm DL (1965) Interspecies differences in responses to polypeptides as permeability factors. Nature 208:653–655
Haddy FV, Emerson TE, Scott SB, Dougherty RM (1970) The effects of kinins on the cardiovascular system. Handbook Exp Pharmacol 25:362–384
Holm S (1979) A simple sequentially multiple test procedure. Scand J Statist 6:65–70
Johnson AR, Erdos EG (1983) Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med 142:1252–1256
Longridge DJ, Schachter M, Stewart JM, Uchida Y, Vavrek RJ (1986) Synthetic competitive antagonists of bradykinin on vascular permeability in the rabbit. J Physiol 372: 73 P
Marceau F, Knap M, Regoli D (1981) Pharmacological characterisation of the vascular permeability enhancing effects of kinins in the rabbit skin. Cancer J Phys Pharmacol 59:921–926
Marceau F, Lussier A, Regoli D, Giroud JP (1983) Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharmacol 14:209–230
Regoli D, Barabe J (1980) Pharmacology of bradykinin and related kinins. Pharmacol Rev 32:1–46
Regoli D, Drapeau G, Rovero P, Dion S, D'Orleans Juste P, Barabe J (1986) The actions of kinin antagonists on B1- and B2-receptor systems. Eur J Pharmacol 123:61–65
Reis ML, Okino L, Roch A, Silva M (1971) Comparative pharmacological actions of bradykinin and related kinins of larger molecular weights. Biochem Pharmacol 20:2935–2946
Rioux F, Kérovac R, St-Pierre S (1985) Potency of various peptides as histamine liberators in the rat hind limb. Neuropeptides 6:311–319
Schild HO (1947) pAx, A new scale for the measurement of drug antagonism. Br J Pharmacol 2:189–206
Spector WG (1958) Substances which affect capillary permeability. Pharm Rev 10:475–505
Stewart JM, Vavrek RJ, Whalley ET (1986) Antagonism of the vascular permeability actions of bradykinin in the rabbit. Br J Pharmacol 16:P7
Vavrek RJ, Stewart JM (1985) Competitive antagonists of bradykinin. Peptides 6:161–164
Whalley ET (1987) Vascular permeability actions of kinins: a comparative study. Naunyn-Schmiedeberg's Arch Pharmacol 336:99–104
Whalley ET, Amure YO, Lye RH (1987) Analysis of the mechanism of action of bradykinin on human basilar artery in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 335:433–437
Whalley ET, Sampaio CAM, Fritz H, Edwards G (1984) The effect of kinins on paw oedema and uterus in rats. Naunyn-Schmiedeberg's Arch Pharmacol 328:202–206
Wilhelm DL (1973) Chemical mediators. In: Zweifach BW, Grant L, McGluskey RT (eds) The inflammatory process, 2nd edn, vol 2. Academic Press, New York, pp 251–301
Author information
Authors and Affiliations
Additional information
Send offprint requests to E. T. Whalley
Rights and permissions
About this article
Cite this article
Whalley, E.T., Nwator, I.A., Stewart, J.M. et al. Analysis of the receptors mediating vascular actions of bradykinin. Naunyn-Schmiedeberg's Arch Pharmacol 336, 430–433 (1987). https://doi.org/10.1007/BF00164878
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00164878